CTSO : Summary for Cytosorbents Corporation - Yahoo Finance

U.S. Markets close in 2 hrs 29 mins

Cytosorbents Corporation (CTSO)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.350.00 (0.00%)
As of 1:27 PM EST. Market open.
People also watch:
AEMDELTPADXSONCSIGXT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close5.35
Open5.45
Bid5.35 x 2000
Ask5.40 x 600
Day's Range5.30 - 5.45
52 Week Range3.11 - 7.40
Volume14,753
Avg. Volume88,728
Market Cap136.26M
Beta-0.66
PE Ratio (TTM)-14.23
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    CytoSorb® Attains Permanent, Dedicated Reimbursement Code in Core Market of Germany

    MONMOUTH JUNCTION, N.J., Dec. 7, 2016 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification therapy  to treat deadly inflammation in critically-ill and cardiac surgery patients across 42 countries, announces the achievement of a permanent, dedicated reimbursement procedure code for the CytoSorb® therapy in Germany, providing for specific and enhanced reimbursement in the largest medical device market in Europe. Dr. Christian Steiner, Vice President of Sales and Marketing for CytoSorbents stated, "We have worked diligently for the past several years to attain this key foundational milestone that is expected to catalyze major increases in adoption and sales of CytoSorb in Germany.

  • PR Newswire7 days ago

    CytoSorbents to Present at the LD Micro Main Event Investor Conference

    MONMOUTH JUNCTION, N.J., Dec. 2, 2016 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO ), a critical care immunotherapy leader commercializing its European Union approved CytoSorb ® cytokine adsorber ...

  • PR Newswire8 days ago

    CytoSorb® Selected for NICE MedTech Innovation Briefing in the United Kingdom

    MONMOUTH JUNCTION, N.J., Dec. 1, 2016 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb ® cytokine adsorber ...